- AI in PV
- AI Implementation
- AI Training
- AI Compliance
- Regional Coverage
- Expertise
- QPPV Services
- Medical Safety
- Aggregate Reports
- Signal and Risk Management
- Audits and Due Diligence
- Training and Consultancy
- Digital Transformation
- Technology
iVigee, pharmacovigilance architects and providers of high-added value services to the pharmaceutical industry are pleased to announce that Roy Ovel is to join their team as an advisor, and subject to formal approval will join the Board as a Non-executive Director.
Jan Petracek, CEO said, 201C Roy is an experienced Non-Executive Director and Board member, facilitating the growth of a diverse range of companies. With over 35 years of experience in the pharmaceutical industry, Roy is a highly customer focussed leader and advisor. I value his ability to take a holistic approach to business. He has developed a reputation for developing potential and growing revenues and profitability to ensure growth. He has led commercial growth strategies across a wide range of geographical territories, and we welcome his support at iVigee 201D.
Roy said 201CI am really excited to be supporting such an innovative company that provides trustworthy, tailored, high-quality solutions to the industry. The company combines both highly qualified professionals with innovative technologies like iVireg, an industry-leading knowledge management system, to provide outstanding support to its clients.